BRAIN STEM GLIOMA

 

BRAIN STEM GLIOMA

 

DEFINITION:

A neuroglial solid tumor of the brain stem characterized by obstructive hydrocephalus and cerebellar signs.

EPIDEMIOLOGY:

  • incidence: ?
    • 3rd most common tumor of the posterior fossa
    • accounts for 10% of all pediatric brain tumors
  • age of onset:
    • peak age: 5-10 yrs
  • risk factors:
    • M = F

PATHOGENESIS:

1. Tumor Origin

  • pons > medulla > midbrain
  • obstructive hydrocephalus results from the local extension of the tumor mass along white matter tracts and into the cere-bellar peduncles, 4th ventricle, ependymal, and subarachnoid spaces
  • tumor may be:

1. Diffuse

  • most common type of brain stem glioma
  • arise in the pons
  • usually anaplastic astrocytoma with poor survival

2. Focal

  • isolated cystic or solid tumor in medulla & brain stem
  • most often low-grade astrocytoma
  • 5 yr survival: 50-60%

3. Exophytic

  • dorsal - penetrate thru the ependymoma into the 4th ventricle causing obstructive hydrocephalus
  • less malignant pathology with good prognosis
  • lateral - invade the 7th & 8th CN as they exit the brainstem
  • mainly malignant with poor prognosis
  • cervico- - involve the cervicomedullary junction medullary - generally low-grade tumor with good progno.

2. Histologic Types

  • histogically these tumors are composed of a heterogeneous group of gliomas
  • malignant (60-70%)
    • anaplastic astrocytoma, glioblastoma multiforme
  • low grade (30-40%)
    • astrocytomas (low grade), gangliogliomas, JPA
  • may be associated with a deletion of chrom. 9p

3. Poor Prognosticators

  • diffuse malignant subgroup:
    • short duration of symptoms
    • bilateral CN dysfunction
    • large volume of residual tumor
    • diffuse hypointensity on MRI

CLINICAL FEATURES:

1. Primary Tumor

  • depend on whether the tumor is diffuse, focal, or exophytic
  • 30% will have hydrocephalus

1. Diffuse

  • have symptoms lasting wks -> months (rapid growth)
  • common triad reflects diffuse brain stem involvement:
    • ataxia
    • bilateral dysfunction of the cranial nerves
    • long tract signs

2. Focal

  • more isolated and have protracted symptoms (mo.-> yrs)
  • behavioral changes with varying combinations of unilateral deficits: - cerebellar
    • cranial nerves (6th, 7th)
    • upper motor signs (pyramidal tract signs)

3. Exophytic

  • dorsal - obstructive hydrocephalus with increased ICP & protracted vomiting, FTT
  • lateral - facial and auditory nerve dysfunction
  • cervico- - neck pain, dysfunction of the lower CN, medullary spastic quadriparesis

2. Metastases

  • 1. Leptomeninges - rare (< 15%)
  • INVESTIGATIONS:

    1. Imaging Studies

  • 1. MRI

    • T2-weighted imaging
    • diffuse - symmetric pontine enlargement
    • focal - localized signal
    • exophytic - dorsal, lateral, and cervicomedullary enhancing
  • 2. Pathology

    • tumor

    3. Biologic

    • CSF - cytology

    MANAGEMENT:

    1. Surgery (based on tumor origin)

    • Diffuse - empirical radiation wtih surgery not indicated
    • Focal - surgery indication for histologic typing, tumor removal, cyst drainage, and relief of obstructed CSF
    • Exophytic - surgery indicated for all types with same indications as for focal type
    • most recurrences occur in the post. fossa (80-90%) or neuroaxis (15%) within 18 months with only a <10% survival rate; treatment consists of reoperation, radiation, and salvage chemotherapy

    2. Radiation (adjuvant)

    • doses of >5,000 cGy will increase survival rates
    • local field radiation since recurrence usually in poster. fossa
    • used in all cases except if tumor ganglioglioma or JPA
    • may use hyperfractionated protocol (bid)

    3. Chemotherapy (adjuvant)

    • benefit not yet proven
    • CCNU, vincristine, prednisone

     

     

    Pediatric Database - BRAIN STEM GLIOMA

    Pediatric Organization - Pedbase [at] Gmail.com